 |
Glycomine
Last updated: May 24, 2025
CEO - Steven Axon
USA | Funding: $195M (+)
Website: https://www.glycomine.com/
Glycomine is an early-stage biotech working on replacement therapies for rare diseases.
Website: https://www.glycomine.com/
Glycomine is an early-stage biotech working on replacement therapies for rare diseases.
